<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04521725</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00097797</org_study_id>
    <nct_id>NCT04521725</nct_id>
  </id_info>
  <brief_title>Effect of Monitoring Devices on Healthcare Provider Performance During Neonatal Resuscitation</brief_title>
  <official_title>Effect of Additional Monitoring Devices on Healthcare Provider Mental Workload, Visual Attention, and Performance During Neonatal Resuscitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Babies born very early (at less than 32 weeks) usually need help to breath right at birth,&#xD;
      also called neonatal resuscitation. Healthcare providers (HCPs) are specially trained to&#xD;
      provide this help. HCPs uses information about the baby's condition, such heart rate and&#xD;
      oxygen levels, to decide whether they giving the baby effective help, or whether other&#xD;
      actions are needed. It can be very stressful for even experienced HCPs to interpret all this&#xD;
      data, coordinate a team, make decisions, and perform specialized skills all at the same time.&#xD;
&#xD;
      More recently, new ways of monitoring how a baby is doing neonatal resuscitation has been&#xD;
      studied. Respiratory function monitoring (RFM) is a machine that can measure how much air is&#xD;
      going into the lungs. This is important as too much air can lead to lung damage, while too&#xD;
      little air means that the baby isn't breathing effectively. Another measure is called&#xD;
      cerebral near-infrared spectroscopy (cNIRS), which measures oxygen levels in the brain using&#xD;
      a probe placed on the forehead. Providing the right amount of oxygen to the most vulnerable&#xD;
      organ - the brain - can be important in lowering the risk for injuries to the brain such as&#xD;
      brain bleeding. While these machines give us more information, it can also make it even&#xD;
      harder for HCPs to focus on the task, adding more complexity to making decisions, adding to&#xD;
      their workload, and causing more stress.&#xD;
&#xD;
      To study the effect RFM and cNIRS may have on how affects HCPs workload and stress, the&#xD;
      investigators will study HCPs self-reported workload during three time periods - first, doing&#xD;
      resuscitations only using basic information (Group 1: heart rate, oxygen levels, direct&#xD;
      observations of the baby), second, adding RFM (Group 2), finally adding both RFM and cNIRS&#xD;
      (Group 3). A survey called NASA Task Load Index will be used to study HCPs workload. On a&#xD;
      small number of teams, the investigators will also track where the leader of the team is&#xD;
      looking using eye-tracking glasses, how stressed the leader is by measuring their heart rate,&#xD;
      skin sweat, and pupil dilation. Finally, the investigators will collect some information&#xD;
      about the baby's resuscitation and hospital stay.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to study 93 resuscitations of very preterm infants (23+0-31+6 weeks),&#xD;
      in consecutive groups of 31. First, as a baseline, 31 infants will be resuscitated using the&#xD;
      standard approach, with vital signs monitoring only. Subsequently, 31 infants will be&#xD;
      resuscitation with the addition of Respiratory Function Monitor (RFM) to measure VT. Finally,&#xD;
      31 infants will be resuscitated using vital signs monitor, RFM, and cerebral near-infrared&#xD;
      spectroscopy (NIRS). Study participants will be health care providers, and the primary&#xD;
      endpoint is based on the recruitment of 93 team leaders (31 in each group). Other team&#xD;
      members will also be recruited, to an estimate of 3-5 team members per resuscitation in total&#xD;
      (N=279 to 465). Throughout the study, HCPs will be trained to incorporate the use of RFM and&#xD;
      NIRS in their resuscitation decision-making, using a combination of weekly in-situ&#xD;
      simulations and incorporation of NIRS and RFM teaching into ongoing resuscitation team&#xD;
      educational sessions and practice updates. Suggested tidal volume and NIRS goals will be&#xD;
      posted as cognitive aids in the resuscitation rooms throughout the study. This sequential&#xD;
      approach will allow for resuscitation teams to become acclimatized to the use of RFM and NIRS&#xD;
      as routine practice. The sequential approach will also allow the investigators to study&#xD;
      time-based changes in perceived mental workload as teams acclimatize to the use of additional&#xD;
      monitoring.&#xD;
&#xD;
      After each resuscitation, all team members involved will be asked to complete a brief&#xD;
      workload questionnaire (NASA-Task Load Index), which will be linked to the resuscitation.&#xD;
      Resuscitations will be video-recorded for analysis of i) resuscitation steps required (e.g.&#xD;
      basic steps, bag-mask ventilation, endotracheal intubation, chest compressions, medications),&#xD;
      and ii) frequency of use of additional monitoring data (RFM, NIRS) for decision-making. In a&#xD;
      subset of resuscitations, the team leader will also be equipped with eye-tracking glasses to&#xD;
      record visual attention and pupillary dilatation, and Empatica wristband to record the team&#xD;
      leader's heart rate and EDA. Parents of the infants will then be approached for permission to&#xD;
      collect more detailed information for the infant's resuscitation and subsequent&#xD;
      hospitalization.&#xD;
&#xD;
      Data will be analyzed to compare i) team leader subjective mental workload, ii) composite&#xD;
      team mental workload, iii) other workload measures (physical demand, temporal demand,&#xD;
      performance, effort, frustration), iii) percentage of visual attention focused on infant,&#xD;
      monitoring devices, and other HCPs, iv) frequency of visual access to each monitor display&#xD;
      type (vital signs, RFM, NIRS), iv) respiratory function (VT, PIP), v) cerebral NIRS, vi) time&#xD;
      to placement of monitoring probes (ECG leads, pulse oximetry, cerebral NIRS), vii) time to&#xD;
      first reading for each monitoring device, and viii) time to target HR and SpO2. The primary&#xD;
      outcome will be the perceived mental workload of the team leader. Data will be compared&#xD;
      between the three groups. In addition, time-dependent changes in team leader and composite&#xD;
      mental workload will also be analyzed using a run chart approach. Deferred consent will be&#xD;
      obtained from each infant's parents / guardians for collection of hospital course data&#xD;
      including: i) incidence of intraventricular hemorrhage, ii) respiratory supports needed, iii)&#xD;
      bronchopulmonary dysplasia at 36 weeks, iv) death / survival to discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Team Leader's NASA Task Load Index (NASA-TLX) Mental Demand</measure>
    <time_frame>Immediately post resuscitation</time_frame>
    <description>Team leader's subjective mental demand as reported by the NASA Task Load Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite team mental workload</measure>
    <time_frame>Immediately post resuscitation</time_frame>
    <description>Team members combined mental workload as measured by NASA Task Load Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Team Leader Visual Attention Distribution</measure>
    <time_frame>During resuscitation</time_frame>
    <description>Percentage of visual attention focused on infant, monitoring devices, and other health care provider as measured by mobile eye-tracking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of visual fixation to monitoring equipment Visual Access to each monitor display type (vital signs, RFM, NIRS)</measure>
    <time_frame>During resuscitation</time_frame>
    <description>Frequency of visual fixation to vital signs monitor, Respiratory function monitoring (RFM) screen, and Near Infrared Spectroscopy (NIRS) screen as measured by eye-tracking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to achieving target heart rate (HR) and oxygen saturation (SpO2)</measure>
    <time_frame>During resuscitation</time_frame>
    <description>Time to achieving target HR and SpO2 for age during resuscitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival to 36 weeks</measure>
    <time_frame>36 weeks</time_frame>
    <description>Survival to 36 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe Intraventricular hemorrhage</measure>
    <time_frame>36 weeks</time_frame>
    <description>Grade III or Grade IV Intraventricular hemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe Bronchopulmonary Dysplasia</measure>
    <time_frame>36 weeks</time_frame>
    <description>Need for â‰¥30% oxygen and/or positive pressure, (PPV or NCPAP) at 36 weeks PMA or discharge, whichever comes first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Team Leader's heart rate during resuscitation</measure>
    <time_frame>During resuscitation</time_frame>
    <description>Team Leader's median heart rate during resuscitation as an indicator of stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Team Leader's electrodermal activity</measure>
    <time_frame>During resuscitation</time_frame>
    <description>Team Leader's electrodermal activity as an indicator of stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to apply all probes</measure>
    <time_frame>During resuscitation</time_frame>
    <description>Time to apply the probes as needed by the group (SpO2, ECG, NIRS)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">93</enrollment>
  <condition>Prematurity</condition>
  <arm_group>
    <arm_group_label>Group1: ECG+SpO2 only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Traditional ECG (heart rate) and SpO2 (pulse oximetry) monitoring for resuscitation only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: ECG+SpO2+RFM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Addition of Respiratory Function Monitor to ECG and SpO2 during resuscitation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: ECG+SpO2+RFM+NIRS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Addition of cerebral NIRS and Respiratory Function Monitor to ECG and SpO2 during resuscitation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respiratory Function Monitor (RFM)</intervention_name>
    <description>Use of respiratory function monitor to detect tidal volume and expired CO2 to guide mask ventilation during neonatal resuscitation.</description>
    <arm_group_label>Group 2: ECG+SpO2+RFM</arm_group_label>
    <arm_group_label>Group 3: ECG+SpO2+RFM+NIRS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cerebral Near-Infrared Spectroscopy (NIRS)</intervention_name>
    <description>Use of cerebral NIRS to determine cerebral oxygenation to guide oxygen titration during neonatal resuscitation.</description>
    <arm_group_label>Group 3: ECG+SpO2+RFM+NIRS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  HCPs participating in resuscitations of very preterm infants (23+0-31+6 weeks) at the&#xD;
             Royal Alexandra Hospital Neonatal Intensive Care Unit (NICU), a Level III NICU will be&#xD;
             included.&#xD;
&#xD;
          -  Multiple gestations will be analyzed individually as separate resuscitations. HCPs&#xD;
             will include different levels of experience and different disciplines (registered&#xD;
             nurses, advance practice nurses, respiratory therapists, neonatal nurse practitioners,&#xD;
             pediatric residents, neonatal fellows, clinical associates, and neonatal consultants).&#xD;
&#xD;
          -  All HCPs who participate in the resuscitation, regardless of role, will be eligible&#xD;
             for completion of NASA-TLX surveys.&#xD;
&#xD;
          -  Participants who act as team leader will be eligible to be fitted with eye-tracking&#xD;
             glasses to record their visual attention and Empatica E4 wristbands to measure&#xD;
             physiological stress measurements.&#xD;
&#xD;
          -  For resuscitated infants, hospital outcomes will be included with parental consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Teams involved in the resuscitation of infants born with congenital malformations, or&#xD;
             involved in the care of infants for whom active resuscitation is not planned (i.e.,&#xD;
             comfort care only for periviable gestations) will be excluded.&#xD;
&#xD;
          -  Teams who do not consent to participate will also be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brenda H Law, MD</last_name>
    <phone>780-745-4647</phone>
    <email>blaw2@ualberta.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Law, MD</last_name>
      <phone>780-735-4647</phone>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 18, 2020</study_first_submitted>
  <study_first_submitted_qc>August 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neonatal resuscitation</keyword>
  <keyword>Human Factors</keyword>
  <keyword>Workload</keyword>
  <keyword>Respiratory Function Monitoring</keyword>
  <keyword>cerebral near infrared spectroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

